As a key member of the executive team, the Chief Medical Officer (CMO) acts as a strategic partner to the Chief Executive Officer and the Foundation Medicine leadership team. This position is responsible for driving the medical team's focus on transforming cancer care through leveraging molecular information to improve clinical and therapeutic development decision-making. The CMO is a critical thought partner in advancing decision insights strategy and effective internal and external communication and collaboration.
The physician executive builds, mentors, and leads the medical team, and provides guidance for future resourcing decisions as the company's portfolio of decision insights assets accelerates. In addition to the strategic development and oversight of the company's existing portfolio, the CMO actively participates in the company's strategic planning, partnering discussions, and presentations to regulatory agencies and the Board of Directors.
Key Responsibilities
Serve as a key member of the Executive Leadership Team, play a key role in the medical strategy and in setting the tactical direction of the current and future development portfolio.
Provide strategic insight and guidance with respect to the clinical or medical needs for strategic direction, product portfolio, and new products and applications.
Lead all aspects of the Company's Medical function.
Establish relationships with thought leaders, consultants, and key clinicians across the varied segments of interest to ensure that the Company has a clear understanding of clinician and biopharma needs and requirements, as well as medical practice patterns.
Serve as the senior clinical spokesperson for a wide range of venues, both internally and externally, such as FDA Advisory Committee meetings, KOL engagement, professional society forums, and relevant Corporate functions.
Actively participate in strategic planning, partnering discussions, and presentations to investors, regulatory agencies, and the Board of Directors; be actively involved in potential partnerships.
Maintain an understanding of competitors and clinical developments in relevant oncology, data, technology, and medical decision making and analyze the competitive landscape delivering meaningful results for the organization.
Lead the Company's clinical and regulatory programs to diverse audiences including FDA or EMA, shareholders, corporate partners, Board of Directors, and other key stakeholders.
Attract, develop, and retain top talent, lead strategic and operational aspects for medical functions.
Other duties as assigned.
Qualifications
Basic Qualifications
MD
10+ years of progressive work experience in scientific or medical roles within life sciences
Preferred Qualifications
15+ years of Clinical Development leadership experience, preferably as a CMO or oncology Vice President leading the clinical strategy in a companion diagnostic, biotech, or pharmaceutical organization
Extensive experience working in oncology
Experience in development and implementation of innovative clinical trials and evidence generation strategies
Experience in the principles and techniques of data analysis, interpretation, and clinical relevance
Experience in delivery of scientific communications
Experience creating and managing effective internal and external relationships, such as with members of SABs, global regulatory agencies, partners, KOLs, etc.
Proven track record of effective team development, leadership and management experience across multiple cultures
History of leading the clinical vision and the design and execution of effective clinical development and regulatory strategies
Proven ability to work in an entrepreneurial environment, operating at strategic levels while also able to roll up your sleeves and get into the details
Track record of driving clinical programs in collaborations with industry partners
Leadership experience building a medical infrastructure
Expert knowledge in Medical Decision Making and Evidence Based Medicine applications
Knowledge of the overall drug discovery, development, and commercialization process relevant to pharmaceutical/biotechnology organizations
A strong understanding in genomics and oncology, with a network of biotech, oncology, diagnostic, data/technology and venture capital contacts
Knowledge of clinical application of liquid biopsy technologies to understand drug resistance for selecting targeted therapies
Excellent communication, interpersonal and negotiation skillset
Understanding of HIPAA and the importance of patient data privacy
Commitment to reflect FMI's values: passion, patients, innovation, and collaboration
Foundation Medicine, Inc. (FMI) began with an idea - to simplify the complex nature of cancer genomics, bringing cutting-edge science and technology to everyday cancer care. Our approach generates insights that help doctors match patients to more treatment options and helps accelerate the development of new therapies. Foundation Medicine is the culmination of talented people coming together to realize an important vision, and the work we do every day impacts real lives.
Foundation Medicine is proud to be an Equal Opportunity and Affirmative Action employer and considers all qualified applicants for employment without regard to race, color, religion, sex, gender, sexual orientation, gender identity, ancestry, age, or national origin. Further, qualified applicants will not be discriminated against on the basis of disability or protected veteran status. We also consider qualified applicants regardless of criminal histories, consistent with legal requirements. See also FMI's EEO Statement and EEO is the Law and Supplement . If you have a disability or special need that requires accommodation, please let us know by completing this form . (EOE/AAP Employer)